[Guangming visits famous experts and focuses on 25 science and technology workers who write letters to the general secretary]
"After receiving the reply, I am very happy because General Secretary Xi Jinping put forward a very loud statement-innovation is the first driving force to lead development, and technology is a powerful weapon to overcome difficulties." As one of the writers, the Chinese Academy of Engineering Academician Zhong Nanshan was greatly encouraged.
"Writing this letter to General Secretary Xi Jinping, I felt at that time that our country was still constrained by people in many key core areas. Under this pressure, we must promote independent innovation and promote the integration of industry, academia and research, that is, science and technology should be integrated with the economy. ." Zhong Nanshan talked about the original intention of writing a letter.
"In the future, we must not only work hard on innovation, but also combine science and technology with the economy, in order to truly realize what the general secretary said, "Science and technology is a powerful weapon to overcome difficulties." Have a clearer understanding of the future direction of science and technology workers.
Zhong Nanshan said so, even more so. On June 16, participated in the Severe Lung Cancer Special Forum in Guangzhou; on June 17, he was busy all day in the State Key Laboratory; on the morning of June 18, Zhong Nanshan was connected to the University of Sydney, Australia at the First Affiliated Hospital of Guangzhou Medical University, Introduced China's experience in combating the new coronavirus, and answered questions raised by the University of Sydney and the Australian and Chinese media. In the afternoon, Zhong Nanshan and Vice President Zheng Jinping of the Guangzhou Huyan Research Institute discussed scientific research. A few days ago, the First Affiliated Hospital of Guangzhou Medical University announced his itinerary in recent days. It is no exaggeration to describe it as "nonstop".
In this fight against the New Coronary Pneumonia epidemic, Zhong Nanshan, who has always focused on innovation, has further strengthened his ideas. "The entire anti-epidemic process fully embodies this, because new coronary pneumonia has not been encountered in the world, how it occurs, how it is transmitted, what is the route of infection, and what is the cause of its incidence, how to diagnose, how to treat, how to prevent "It's all new, so science and technology workers are in great need to exert their creativity and treat them with an innovative spirit." Zhong Nanshan said.
"The First Affiliated Hospital of Guangzhou Medical University where I am working has treated almost all the critically ill patients in Guangzhou, the heaviest cases, we rescued 19, and all were cleared on May 27. In this anti-epidemic, we There is no lesson to learn from, and we do not have references to foreign materials. We are all crossing the river by touching stones. Many medical personnel and many scientific and technological workers have achieved some results in prevention, upstream prevention and control strategies, and early diagnosis." Zhong Nanshan said .
According to relevant statistics, as of early May of this year, a total of 2151 articles have been published on new coronary pneumonia in the world. Zhong Nanshan introduced that 650 articles were published in my country, accounting for almost one third, and many of them were published in top magazines. "These articles provide very good experience in guiding how to prevent and control the world, and in some ways play a guiding role," he said.
"We have also developed some methods-Chinese methods, especially to prevent patients from developing from common to severe, from severe to critically ill. In this process, some Chinese medicines have also played a good role. Among them, one or two of them have been recognized by the international academic community, so this has also played a great role in Chinese medicine going to the world." Zhong Nanshan affirmed the role of Chinese medicine in suppressing the outbreak of new coronary pneumonia.
When talking about the progress of vaccine research and development that the public is very concerned about, Zhong Nanshan made it clear that my country's vaccine research progress is the first echelon in the world. "Whether it is an RNA vaccine or an inactivated whole virus vaccine, now we have five vaccines that have reached the second phase of clinical trials, and our speed is not slow." Zhong Nanshan said.
Reporter Wang Zhongyao Wu Chunyan